21 C.F.R. § 333.280
Professional labeling.
Cite as 21 C.F.R. § 333.280 (2026)
The labeling provided to health professionals (but not to the general public) may contain the following additional indication:
(a)
For products containing haloprogin or miconazole nitrate identified in § 333.210 (a) and (c).
“For the treatment of superficial skin infections caused by yeast (
Candida albicans
).”
(b) [Reserved]
- Cross-references to the CFR
- 333.210